A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Recruiting
N/A
Interventional Study
Breast Carcinoma
Colorectal Carcinoma
Lung Carcinoma
Malignant Solid Neoplasm
Prostate Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 80 (estimated)
- Sponsor
- University of Michigan Rogel Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, potentially life-threatening toxicities, and drug-drug and drug-food interactions at home. To achieve…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Participants are adult patients (aged 18 years or older)
* Diagnosed with lung, colorectal, breast, or prostate cancer
* Are currently receiving active cancer treatments
* Are self-managing one or more prescribed cancer medications
* Participants must have access to technology…
Contacts